Global Cancer Biopsy Market

A biopsy is the removal of tissue from any part of the body to examine it for disease. Some may remove a small tissue sample with a needle while others may surgically remove a suspicious nodule or lump. Biopsies are frequently used to diagnose cancer, but they can help identify other conditions such as infections and inflammatory and autoimmune disorders. They may also be done to match organ tissue before a transplant and to look for signs of organ rejection following a transplant. The market for cancer biopsy worldwide is expected to reach USD 43,692 million by 2028, recording a CAGR of 10.7% over the forecast period as per the latest report by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global cancer biopsy market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the cancer biopsy industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the component, disease indication, biopsy type, and region. The global market for cancer biopsy can be segmented by component: instruments, kits & consumables, services. Cancer biopsy market is further segmented by disease indication: blood cancer, breast cancer, cervical cancer, colorectal cancer, kidney cancer, liver cancer, lung cancer, ovarian cancer, pancreatic cancer, prostate cancer, skin cancer, others. Based on biopsy type, the cancer biopsy market is segmented into: tissue biopsies, liquid biopsies, others. On the basis of region, the cancer biopsy market also can be divided into: North America, Asia Pacific, Europe, Rest of the World (ROW).

By component:
– instruments
– kits & consumables
– services

By disease indication:
– blood cancer
– breast cancer
– cervical cancer
– colorectal cancer
– kidney cancer
– liver cancer
– lung cancer
– ovarian cancer
– pancreatic cancer
– prostate cancer
– skin cancer
– others

By biopsy type:
– tissue biopsies
– liquid biopsies
– others

By region:
– North America
– Asia Pacific
– Europe
– Rest of the World (ROW)

The market research report covers the analysis of key stake holders of the global cancer biopsy market. Some of the leading players profiled in the report include ANGLE plc, Becton, Dickinson and Company, Biocept, Inc., Biodesix, Inc. (Integrated Diagnostics), Danaher Corporation, Exact Sciences Corporation, F. Hoffmann-La Roche AG, Freenome Holdings, Inc., GRAIL, LLC, Guardant Health, Inc., Helio Health Inc., Hologic, Inc., Illumina, Inc., Lucence Health Inc., Myriad Genetics, Inc., Oncimmune Holdings PLC, Qiagen N.V., Thermo Fisher Scientific, Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global cancer biopsy market.
– To classify and forecast the global cancer biopsy market based on component, disease indication, biopsy type, region.
– To identify drivers and challenges for the global cancer biopsy market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global cancer biopsy market.
– To identify and analyze the profile of leading players operating in the global cancer biopsy market.

Why Choose This Report
– Gain a reliable outlook of the global cancer biopsy market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.

Global Cancer Biopsy Market

Interested in this report? Get your FREE sample now!
Global Cancer Biopsy Market - Report Scope
REPORT ATTRIBUTE

DETAILS

Base Year

2021

Forecast Year

2022-2028

CAGR (2022-2028)

10.7%

Pages

90

Key Players

ANGLE plc, Becton Dickinson and Company, Biocept Inc., Biodesix Inc. (Integrated Diagnostics), Danaher Corporation, Exact Sciences Corporation, F. Hoffmann-La Roche AG, Freenome Holdings Inc., GRAIL LLC, Guardant Health Inc., Helio Health Inc., Hologic Inc., Illumina Inc., Lucence Health Inc., Myriad Genetics Inc., Oncimmune Holdings PLC, Qiagen N.V., Thermo Fisher Scientific Inc.

Related Reports
Global Scar Management Market 2023

The global scar management market, in terms of revenue, is anticipated to progress at a CAGR of 5.8% during the forecast period, 2023-2029. Scar management encompasses various techniques and treatments…

READ MORE

$2,200.00

Want to customize this report?
The present report possesses the flexibility to be tailored to your specific needs. Our team of analysts and industry experts will collaborate directly with you to gain a comprehensive understanding of your requirements.
Scroll to Top

Download Free Sample - Global Cancer Biopsy Market

Please fill out our form and we will get back to you.